ACOG Practice Bulletin no. Anemia in pregnancy. Article type [CB]. Practice Guidelines. Citation [CB]. Obstet Gynecol ; Appropriate evaluation and treatment of anemia in pregnancy; Iron of Obstetricians and Gynecologists (ACOG); Jul. 7 p. (ACOG practice bulletin; no. 95). Anemia, the most common hematologic abnormality, is a reduction in the concentration of erythrocytes or hemoglobin in blood. The two most common causes of.

Author: Moogunos Takree
Country: Togo
Language: English (Spanish)
Genre: Technology
Published (Last): 26 May 2017
Pages: 321
PDF File Size: 11.80 Mb
ePub File Size: 15.65 Mb
ISBN: 930-1-14202-607-4
Downloads: 35924
Price: Free* [*Free Regsitration Required]
Uploader: Doshakar

Recommendations are provided bulpetin antiretroviral therapies in pregnant women with HIV Annals of Internal Medicine; 4: The USPSTF reviewed the evidence on the association between change in iron status as a result of intervention oral supplementation or treatment in pregnant women and adolescents and improvement in maternal and infant health outcomes. Measurement of serum hemoglobin or hematocrit levels is often the first step used in primary care practice.

ACOG Practice Bulletin no. 95. Anemia in pregnancy

Users may make print copies for use as hand-outs anekia the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP.

The USPSTF found inadequate evidence on the harms of routine screening for iron deficiency anemia in asymptomatic pregnant women.

Evidence on the association between improvement in maternal iron status and improvement in maternal and infant health outcomes is lacking. The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for iron deficiency anemia in pregnant women to prevent adverse maternal health and birth outcomes.


It can develop as a result of an increased need for iron for example, during pregnancydecreased ahemia intake and absorption for example, lack of iron sources in the dietor a loss of iron for example, bleeding.

The following recommendations and conclusions are based on limited or inconsistent evidence Level B: The implementation of targeted temperature management: Clinical Guidelines 6 October From This Paper Topics from this paper.

You need a subscription to this content to use this feature. Open Athens Shibboleth Log In. Don’t have an account?

By continuing to use our website, you are agreeing to our privacy policy. Iron status markers and serum erythropoietin in mothers and pdactice infants. Iron deficiency anemia during pregnancy has been associated with an increased risk of low birth weight, preterm delivery, and perinatal mortality.

Evidence on the effects of supplementation on birthweight was mixed.

There is little evidence that iron supplementation results in morbidity beyond gastrointestinal symptoms, except in patients with hemochromatosis or certain other genetic disorders.

Although the USPSTF sought this information, limitations in the evidence prevented it from performing separate analyses. No electronic copies available Print copies: Members of the U. Screening for iron deficiency anemia in young children is addressed in a separate recommendation statement available at www.

Anemia in pregnancy.

However, based on anecdotal evidence, it is probably common. Of the 6 studies reporting on low birthweight 12, 13, 16, 17, 21, 22only 1 21 found a significantly lower rate of low-birthweight infants; however, these studies may have been underpowered to detect a change.


The USPSTF concludes that the evidence of the effect of routine screening for iron deficiency anemia in asymptomatic pregnant women on maternal health and birth outcomes is insufficient. The aims of iron supplementation or screening for and treatment of iron deficiency anemia in pregnant women are to improve maternal and infant health outcomes.

The incidence of preterm deliveries and low birth weight babies were significantly more in mothers who were anemic in the third trimesters of pregnancy. Given the lack of studies on screening, the USPSTF did not find sufficient evidence to determine the balance of benefits and harms of screening for iron deficiency anemia and thus cannot make a recommendation in favor of or against screening.

In high-risk pregnant women, an individualized lifestyle intervention reduced gestational diabetes mellitus Annals of Internal Medicine; Most reported harms, including nausea, constipation, and diarrhea, were transient and not serious. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

ACOG Practice Bulletin No. anemia in pregnancy.

The USPSTF considered studies conducted in settings similar to the United States in rates of malnutrition, hemoparasite burden, and general socioeconomic status. Australian clinical practice guideline.

MastiholiManjunath S.

Author: admin